Enterprise Value
288.3M
Cash
118.9M
Avg Qtr Burn
-11.22M
Short % of Float
7.09%
Insider Ownership
0.25%
Institutional Own.
-
Qtr Updated
03/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
AV-101 Details Pulmonary arterial hypertension | Phase 2/3 Data readout |